Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia.
Bromocriptine is a dopamine agonist with potential mental side effects. The authors report a case involving a patient with neuroleptic-induced remission of psychiatric symptoms in whom bromocriptine was associated with temporary exacerbation of schizophrenic symptoms. Other treatment approaches than bromocriptine are suggested for amenorrhea-galactorrhea induced by neuroleptic medication. The use of bromocriptine requires monitoring for changes in mental status.
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced / Q000188:drug therapy; D001971:Bromocriptine / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use*; D008972:Molindone / Q000627:therapeutic use*; D011247:Pregnancy; D012559:Schizophrenia / Q000139:chemically induced* / Q000188:drug therapy; D013888:Thiothixene / Q000627:therapeutic use*
D007211:Indoles; D001971:Bromocriptine; D013888:Thiothixene; D007099:Imipramine; D008972:Molindone